Fluctuation of serum C3 levels reflects disease activity and metabolic background in patients with IgA nephropathy

Journal of Nephrology

Volumn 26, Issue 4, 2013, Pages 708-715

  Suzuki, Hiyori ^a   Ohsawa, Isao ^a   Kodama, Fumiko ^a   Nakayama, Kazutaka ^a   Ohtani, Atsuko ^a   Onda, Kisara ^a   Nagamachi, Seiji ^a   Kurusu, Atsushi ^a   Suzuki, Yusuke ^a   Ohi, Hiroyuki ^b   Horikoshi, Satoshi ^a   Tomino, Yasuhiko ^a  

^a Division of Nephrology   (Japan)

^b Department of Internal Medicine   (Japan)

Author keywords

IgA nephropathy; Metabolic syndrome; Serum C3

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CHOLESTEROL; COMPLEMENT COMPONENT C3; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROTEIN; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL OBSERVATION; COMPLEMENT COMPONENT C3 BLOOD LEVEL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FUNCTIONAL STATUS; GLOMERULUS FILTRATION RATE; HEMATURIA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; MALE; METABOLIC DISORDER; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTEINURIA;

ADULT; COMPLEMENT C3; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; MALE;

EID: 84880121440     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000278     Document Type: Article

References (19)

1. Tomino Y, Suzuki S, Imai H, et al. Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal. 2000;14(5): 220-223.
2. Nakayama K, Ohsawa I, Maeda-Ohtani A, Murakoshi M, Horikoshi S, Tomino Y. Prediction of diagnosis of immunoglobulin A nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading. J Clin Lab Anal. 2008;22(2):114-118.
3. Maeda A, Gohda T, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy. J Clin Lab Anal. 2003;17(3):73-76.
4. Endo M, Ohi H, Satomura A, et al. Regulation of in situ complement activation via the lectin pathway in patients with IgA nephropathy. Clin Nephrol. 2001;55(3):185-191.
5. Oortwijn BD, Eijgenraam JW, Rastaldi MP, Roos A, Daha MR, van Kooten C. The role of secretory IgA and complement in IgA nephropathy. Semin Nephrol. 2008;28(1): 58-65.
6. Ohsawa I, Ishii M, Ohi H, Tomino Y. Pathological scenario with the mannose-binding lectin in patients with IgA nephropathy. J Biomed Biotechnol. 2012;2012:476739.
7. Onda K, Ohi H, Tamano M, et al. Hypercomplementemia in adult patients with IgA nephropathy. J Clin Lab Anal. 2007; 21(2):77-84.
8. Weyer C, Tataranni PA, Pratley RE. Insulin action and insulinemia are closely related to the fasting complement C3, but not acylation stimulating protein concentration. Diabetes Care. 2000;23(6):779-785.
9. Ohsawa I, Inoshita H, Ishii M, et al. Metabolic impact on serum levels of complement component 3 in Japanese patients. J Clin Lab Anal. 2010;24(2):113-118.
10. Matsuo S, Imai E, Horio M, et al. Collaborators Developing the Japanese Equation for Estimated GFR. Revised quations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982-992.
11. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T. Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. Intern Med. 2004;43(11):1023-1028.
12. Oortwijn BD, Rastaldi MP, Roos A, Mattinzoli D, Daha MR, van Kooten C. Demonstration of secretory IgA in kidneys of patients with IgA nephropathy. Nephrol Dial Transplant. 2007;22(11):3191-3195.
13. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol. 2001;167(5):2861-2868.
14. Roos A, Rastaldi MP, Calvaresi N, et al. Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease. J Am Soc Nephrol. 2006;17(6):1724-1734.
15. Kim SJ, Koo HM, Lim BJ, et al. Decreased circulating C3 levels and mesangial C3 deposition predict renal outcome in patients with IgA nephropathy. PLoS ONE. 2012;7(7): e40495.
16. Sato N, Ohsawa I, Nagamachi S, et al. Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis. Lupus. 2011;20(13):1378-1386.
17. Eknoyan G. Obesity and chronic kidney disease. Nefrologia. 2011;31(4):397-403.
18. Halkes CJ, van Dijk H, de Jaegere PP, et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expandeddose simvastatin. Arterioscler Thromb Vasc Biol. 2001;21(9): 1526-1530.
19. Ohsawa I, Kusaba G, Ishii M, et al. Extraglomerular C3 deposition and metabolic impacts in patients with IgA nephropathy. Nephrol Dial Transplant. In press.